298 related articles for article (PubMed ID: 34666694)
1. Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection.
Tsai YC; Sou FM; Liu YW; Wu YJ; Yong CC; Chen DW; Huang PY; Cho WR; Chuang CH; Hsiao CC; Hu TH; Tsai MC
BMC Gastroenterol; 2021 Oct; 21(1):386. PubMed ID: 34666694
[TBL] [Abstract][Full Text] [Related]
2. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
[TBL] [Abstract][Full Text] [Related]
3. Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection.
Amisaki M; Uchinaka E; Morimoto M; Tokuyasu N; Sakamoto T; Honjo S; Saito H; Fujiwara Y
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):502-509. PubMed ID: 30077606
[TBL] [Abstract][Full Text] [Related]
4. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
[TBL] [Abstract][Full Text] [Related]
5. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
[TBL] [Abstract][Full Text] [Related]
6. Modified Child-Pugh grade
Huang F; Gao J
World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
[TBL] [Abstract][Full Text] [Related]
7. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
[TBL] [Abstract][Full Text] [Related]
8. Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery.
Cho WR; Hung CH; Chen CH; Lin CC; Wang CC; Liu YW; Wu YJ; Yong CC; Chen KD; Tsai YC; Hu TH; Tsai MC
Sci Rep; 2020 Apr; 10(1):7290. PubMed ID: 32350365
[TBL] [Abstract][Full Text] [Related]
9. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.
Wang YY; Zhong JH; Su ZY; Huang JF; Lu SD; Xiang BD; Ma L; Qi LN; Ou BN; Li LQ
Br J Surg; 2016 May; 103(6):725-734. PubMed ID: 27005482
[TBL] [Abstract][Full Text] [Related]
10. Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.
Liang X; Liangliang X; Peng W; Tao Y; Jinfu Z; Ming Z; Mingqing X
Sci Rep; 2021 Jul; 11(1):14624. PubMed ID: 34272447
[TBL] [Abstract][Full Text] [Related]
11. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
Luo H; Li C; Chen L
Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
[TBL] [Abstract][Full Text] [Related]
12. Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ
World J Surg; 2018 Jun; 42(6):1841-1847. PubMed ID: 29138913
[TBL] [Abstract][Full Text] [Related]
13. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
[TBL] [Abstract][Full Text] [Related]
14. Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
Ho SY; Yuan MH; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Wang CL; Hou MC; Huo TI
Scand J Gastroenterol; 2023 Jan; 58(1):61-69. PubMed ID: 35830511
[TBL] [Abstract][Full Text] [Related]
15. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
[TBL] [Abstract][Full Text] [Related]
16. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
17. Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy.
Luo H; Huang C; Meng M; Zhang M; Li Z; Huang J
BMC Gastroenterol; 2023 May; 23(1):162. PubMed ID: 37208618
[TBL] [Abstract][Full Text] [Related]
18. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
Kornberg A; Witt U; Schernhammer M; Kornberg J; Müller K; Friess H; Thrum K
J Surg Oncol; 2019 Dec; 120(7):1126-1136. PubMed ID: 31578753
[TBL] [Abstract][Full Text] [Related]
19. Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating
Yoh T; Seo S; Ogiso S; Kawai T; Okuda Y; Ishii T; Taura K; Higashi T; Nakamoto Y; Hatano E; Kaido T; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):542-549. PubMed ID: 29168098
[TBL] [Abstract][Full Text] [Related]
20. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Ho SY; Hsu CY; Liu PH; Hsia CY; Su CW; Huang YH; Hou MC; Huo TI
Eur J Surg Oncol; 2019 May; 45(5):776-781. PubMed ID: 30401507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]